• Home

  • Documents

  • 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug...
18
CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 208686Orig1s000 CHEMISTRY REVIEW(S)

208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development

  • Upload
    haquynh

  • View
    221

  • Download
    8

Embed Size (px)

Citation preview

Page 1: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development

CENTER FOR DRUG EVALUATION AND RESEARCH

APPLICATION NUMBER:

208686Orig1s000

CHEMISTRY REVIEW(S)

Page 2: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 3: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 4: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 5: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 6: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 7: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 8: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 9: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 10: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 11: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 12: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 13: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 14: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 15: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 16: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 17: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 18: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development

Drug Shortages Summit Summary Report

Drug Shortages Summit Summary Report

Documents
Summary of the 2002-2003 Clandestine Drug Laboratory Remediation Survey€¦ · Summary of the 2002-2003 Clandestine Drug Laboratory Remediation Survey California Environmental Protection

Summary of the 2002-2003 Clandestine Drug Laboratory Remediation Survey€¦ · Summary of the 2002-2003 Clandestine Drug Laboratory Remediation Survey California Environmental Protection

Documents
Summary Report on EU Drug Precursors Seizures 2008

Summary Report on EU Drug Precursors Seizures 2008

Documents
Summary of Drug Limitations

Summary of Drug Limitations

Documents
Drug Driving - Summary of Responses Specifying the drugs

Drug Driving - Summary of Responses Specifying the drugs

Documents
125399Orig1s000 - Food and Drug Administration€¦ · center for drug evaluation and research application number: 125399orig1s000 summary review

125399Orig1s000 - Food and Drug Administration€¦ · center for drug evaluation and research application number: 125399orig1s000 summary review

Documents
202806Orig1s000 - Food and Drug Administration · center for drug evaluation and research application number: 202806orig1s000 summary review

202806Orig1s000 - Food and Drug Administration · center for drug evaluation and research application number: 202806orig1s000 summary review

Documents
Medicaid Drug Utilization Review State Comparison/Summary

Medicaid Drug Utilization Review State Comparison/Summary

Documents
La arquitectura residencial de Joaquín Rieta Síster. El

La arquitectura residencial de Joaquín Rieta Síster. El

Documents
200063Orig1s000 - Food and Drug Administration · center for drug evaluation and research application number: 200063orig1s000 summary review

200063Orig1s000 - Food and Drug Administration · center for drug evaluation and research application number: 200063orig1s000 summary review

Documents
KINDReD Final Report: Publishable summary Executive summary · KINDReD Final Report: Publishable summary Executive summary The Kinetoplastid Drug Development (KINDReD) consortium

KINDReD Final Report: Publishable summary Executive summary · KINDReD Final Report: Publishable summary Executive summary The Kinetoplastid Drug Development (KINDReD) consortium

Documents
Prescription Drug Summary of Benefits

Prescription Drug Summary of Benefits

Documents
Your Monthly Prescription Drug Summary - … Monthly Prescription Drug Summary . ... (TTY Spanish) Customer Services ... STAGE 1 : Yearly Deductible

Your Monthly Prescription Drug Summary - … Monthly Prescription Drug Summary . ... (TTY Spanish) Customer Services ... STAGE 1 : Yearly Deductible

Documents
National Drug Threat Assessment Summary 2013

National Drug Threat Assessment Summary 2013

Documents
H.R. 3 - Drug Price Negotiation Bill Summary 3 Drug Pricing Proposal... · H.R. 3 Title Summary TITLE I - Drug Price Negotiation Drug Selection Process k • ff 'th the Every year

H.R. 3 - Drug Price Negotiation Bill Summary 3 Drug Pricing Proposal... · H.R. 3 Title Summary TITLE I - Drug Price Negotiation Drug Selection Process k • ff 'th the Every year

Documents
Global report on antimalarial druG efficacy and druG ... · 3 Global report on antimalarial drug efficacy and drug resistance: 2000–2010 Executive summary BACkground Plasmodium

Global report on antimalarial druG efficacy and druG ... · 3 Global report on antimalarial drug efficacy and drug resistance: 2000–2010 Executive summary BACkground Plasmodium

Documents
Alcohol (Canadian Drug Summary) - ccsa.ca

Alcohol (Canadian Drug Summary) - ccsa.ca

Documents
Drug Treatment Court Feasibility Study · Drug Treatment Court Feasibility Study (May 2017) 1 Executive Summary Drug Treatment Courts are intended for offenders with serious drug

Drug Treatment Court Feasibility Study · Drug Treatment Court Feasibility Study (May 2017) 1 Executive Summary Drug Treatment Courts are intended for offenders with serious drug

Documents
Summary Report on EU Drug Precursors Seizures 2006

Summary Report on EU Drug Precursors Seizures 2006

Documents
WHAT Outline WHY 1. What are Adverse Drug Reactions (ADRs ...€¦ · What are Adverse Drug Reactions (ADRs)? 2. ... Drug Allergy –case summary ... Pictures-from HSA, Adverse Drug

WHAT Outline WHY 1. What are Adverse Drug Reactions (ADRs ...€¦ · What are Adverse Drug Reactions (ADRs)? 2. ... Drug Allergy –case summary ... Pictures-from HSA, Adverse Drug

Documents
World Drug Report 2010 Summary

World Drug Report 2010 Summary

Documents
FY 2014 BUDGET AND PERFORMANCE SUMMARY - … · NATIONAL DRUG CONTROL STRATEGY: FY 2014 Budget and Performance Summary 7 Executive Summary In support of the 2013 National Drug Control

FY 2014 BUDGET AND PERFORMANCE SUMMARY - … · NATIONAL DRUG CONTROL STRATEGY: FY 2014 Budget and Performance Summary 7 Executive Summary In support of the 2013 National Drug Control

Documents
The World Drug Report - Executive Summary Chapter 1: Trends in World Drug Markets Evolution

The World Drug Report - Executive Summary Chapter 1: Trends in World Drug Markets Evolution

Documents
Summary of Drug Limitations - WellCare

Summary of Drug Limitations - WellCare

Documents
203109Orig1s000 - Food and Drug Administration · center for drug evaluation and research application number: 203109orig1s000 summary review

203109Orig1s000 - Food and Drug Administration · center for drug evaluation and research application number: 203109orig1s000 summary review

Documents
204042Orig1s000 - Food and Drug Administration · center for drug evaluation and research application number: 204042orig1s000 summary review

204042Orig1s000 - Food and Drug Administration · center for drug evaluation and research application number: 204042orig1s000 summary review

Documents
NCCP Regimen Information Summary - by Drug Last updated

NCCP Regimen Information Summary - by Drug Last updated

Documents
Methamphetamine (Canadian Drug Summary)...Canadian Drug Summary: Methamphetamine Canadian Centre on Substance Use and Addiction • Centre canadien sur les dépendances et l’usage

Methamphetamine (Canadian Drug Summary)...Canadian Drug Summary: Methamphetamine Canadian Centre on Substance Use and Addiction • Centre canadien sur les dépendances et l’usage

Documents
Boksmart 2010-Recreational Drug Summary - SA Rugby 2010-Recreational Drug... · Recreational Drug Summary Chart 4 DRUG APPEARANCE & PRESENTATION ... / soap / grievous bodily harm

Boksmart 2010-Recreational Drug Summary - SA Rugby 2010-Recreational Drug... · Recreational Drug Summary Chart 4 DRUG APPEARANCE & PRESENTATION ... / soap / grievous bodily harm

Documents
2016 Prescription Drug Abuse Summit Summary At …gov.nv.gov/uploadedFiles/govnvgov/Content/News_and_Media/...2016 Prescription Drug Abuse Summit Summary At A Glance Governor’s Prescription

2016 Prescription Drug Abuse Summit Summary At …gov.nv.gov/uploadedFiles/govnvgov/Content/News_and_Media/...2016 Prescription Drug Abuse Summit Summary At A Glance Governor’s Prescription

Documents